Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Altamira Therapeutics Ltd. buy melinda

Start price
€40.39
19.08.16 / 50%
Target price
€67.65
20.02.17
Performance (%)
-58.60%
End price
€16.72
20.02.17
Summary
This prediction ended on 20.02.17 with a price of €16.72. Massive losses of -58.60% were the result for the BUY prediction by melinda. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Altamira Therapeutics Ltd. - - - -
iShares Core DAX® -0.922% -1.993% 13.399% 16.075%
iShares Nasdaq 100 0.371% -0.868% 41.541% 46.938%
iShares Nikkei 225® 2.224% -5.187% 20.497% 4.643%
iShares S&P 500 -0.026% -0.918% 30.410% 42.418%

Comments by melinda for this prediction

In the thread Altamira Therapeutics Ltd. diskutieren
Prediction Buy
Perf. (%) -58.60%
Target price 67.650
Change
Ends at 20.02.17

fallen zu starten

a +

Prediction Buy
Perf. (%) -58.60%
Target price 67.650
Change
Ends at 20.02.17

(Laufzeit überschritten)

Stopped prediction by melinda for Altamira Therapeutics Ltd.

buy
Altamira Therapeutics Ltd.

Start price
Target price
Perf. (%)
€0.39
25.10.22
€0.60
25.10.23
0.00%
26.10.23

buy
Altamira Therapeutics Ltd.

Start price
Target price
Perf. (%)
€0.65
22.10.22
€1.50
22.10.23
-40.17%
25.10.22

buy
Altamira Therapeutics Ltd.

Start price
Target price
Perf. (%)
€0.58
17.03.20
€1.30
04.11.21
141.38%
05.11.21

buy
Altamira Therapeutics Ltd.

Start price
Target price
Perf. (%)
€18.40
22.10.18
€26.16
30.10.19
-92.34%
30.10.19

buy
Altamira Therapeutics Ltd.

Start price
Target price
Perf. (%)
€6.04
05.02.18
€11.18
14.03.18
389.70%
14.03.18

buy
Altamira Therapeutics Ltd.

Start price
Target price
Perf. (%)
€12.00
26.08.17
€27.06
13.11.17
11.28%
13.11.17

buy
Altamira Therapeutics Ltd.

Start price
Target price
Perf. (%)
€78.83
19.04.16
€108.24
18.08.16
-49.66%
18.08.16